Melissa M Coughlin

8PUBLICATIONS
68CO-AUTHORS
Innate immunityNon-genetically modified uses of biotechnologyInfectious diseasesInfant and child healthGeriatrics and gerontology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 28, 2025
Estimated US Trends in SARS-CoV-2 Spike Antibody Concentrations and Correlation to Risk of First-Time Infections Based on Blood Donations, 2022.

Jefferson M Jones, Eduard Grebe, Isaac Lartey

|Dec 16, 2024
Reply to "Vaccination caused underestimation of cumulative incidence of SARS-CoV-2 infection".

Jefferson M Jones, Melissa M Coughlin, Eduard Grebe

|Jul 25, 2024
Anti-SARS-CoV-2 Antibody Levels Associated With COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu Vaccine Effectiveness Network, October 2021-June 2022.

Kelsey M Sumner, Ruchi Yadav, Emma K Noble

|Mar 11, 2024
Hybrid Immunity and SARS-CoV-2 Antibodies: Results of the HEROES-RECOVER Prospective Cohort Study.

James K Romine, Huashi Li, Melissa M Coughlin

|Nov 28, 2023
Antibody response to symptomatic infection with SARS-CoV-2 Omicron variant viruses, December 2021-June 2022.

Ryan Sandford, Ruchi Yadav, Emma K Noble

|Sep 04, 2023
Humoral Immune Response to Messenger RNA Coronavirus Disease 2019 Vaccination Among Children Aged 5-11 Years in a Multisite Prospective Cohort Study, September 2021-September 2022.

Zoe L Lyski, Cynthia Porter, Jennifer L Uhrlaub

Pageof 2

Frequent Collaborators

3 joint publications

Jefferson M Jones

3 joint publications

Manjusha Gaglani

2 joint publications

Eduard Grebe

2 joint publications

Karen J Wernli